Literature DB >> 3988390

Effect of single and repeated doses of activated charcoal on the pharmacokinetics of doxepin.

M Scheinin, R Virtanen, E Iisalo.   

Abstract

In eight healthy young volunteers, 15 g of activated charcoal administered orally 30 min after 50 mg of doxepin, reduced the achieved peak concentration of the drug in serum by 70% and total availability by 49%. Charcoal, 3 hours after the drug, did not significantly reduce absorption. When charcoal was administered 30 min after doxepin, the apparent elimination half-lives of doxepin and its main metabolite, desmethyldoxepin, were prolonged by 350 and 140%, respectively, suggesting gradual disaggregation of the charcoal-drug complex. Repeated doses of charcoal between 3 and 24 hours after doxepin increased significantly the apparent clearance of desmethyldoxepin. Repeated doses of charcoal may be beneficial in the treatment of overdosage with doxepin by preventing disaggregation of the drug from an initial dose of charcoal with subsequent absorption and reabsorption of parent drug and metabolites secreted into the gastrointestinal tract.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3988390

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther Toxicol        ISSN: 0174-4879


  5 in total

Review 1.  Tricyclic antidepressant overdose: a review.

Authors:  G W Kerr; A C McGuffie; S Wilkie
Journal:  Emerg Med J       Date:  2001-07       Impact factor: 2.740

2.  How useful is activated charcoal?

Authors:  J A Vale; A T Proudfoot
Journal:  BMJ       Date:  1993-01-09

Review 3.  Clinical toxicology.

Authors:  J A Vale
Journal:  Postgrad Med J       Date:  1993-01       Impact factor: 2.401

4.  Effectiveness of delayed activated charcoal administration in simulated paracetamol (acetaminophen) overdose.

Authors:  P J Yeates; S H Thomas
Journal:  Br J Clin Pharmacol       Date:  2000-01       Impact factor: 4.335

Review 5.  Oral activated charcoal in the treatment of intoxications. Role of single and repeated doses.

Authors:  P J Neuvonen; K T Olkkola
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Jan-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.